Connect with us
Finance Digest is a leading online platform for finance and business news, providing insights on banking, finance, technology, investing,trading, insurance, fintech, and more. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.
Research Reports

The Injectable Nanomedicines Market To Witness Innovative Vulnerability Between 2018-2026

Published On :

 

The growth of the injectable nanomedicines market is attributed to the growing use of liposomal drugs and increase in treatment seeking population across the globe. According to a latest research by the company, the global liposomes market is expected to account for revenues over US$ 300 Mn in terms of value by 2026 end. Injectable nanomedicines market is expected to witness significant growth with CAGR pegged at 8.1% through 2026. Manufacturers of injectable nanomedicines are targeting chronic diseases and cancers.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/25999

Company Profiles:

  • Merck & Co., Inc.
  • Lupin
  • Pacira Pharmaceuticals Inc.
  • Celgene Pharmaceutical Co. Ltd.
  • Amgen, Inc.
  • Janssen Biotech Inc. (Sub. Johnson & Johnson Services, Inc.)
  • Pfizer Inc.
  • Hoffmann-La Roche Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Bausch & Lomb Incorporated.
  • Others.

Request for Methodology@ https://www.persistencemarketresearch.com/methodology/25999

Revenues from North America injectable nanomedicines market is expected to expand at significant CAGR and it is estimated to remain as dominant regional market for injectable nanomedicines due to large presence of hospitals and advanced healthcare facilities. Europe is also expected to be one of the leading regional markets for injectable nanomedicines as most of the major academic research institutes and R&D institutes for specialized drugs are located in the region. An ageing population and increasing prevalence of chronic illnesses is estimated to lead to rising demand for injectable nanomedicines.

Injectable nanomedicines are considered as an emerging field with many companies spending on R&D to explore this field in greater depth. There are both small and established market players investing in injectable nanomedicines. Majority of injectable nanomedicines were produced by small pharmaceutical companies which were later acquired by established market players. Small pharmaceutical companies are exploring nanotechnology to develop advanced drugs and technologies.  For instance, Pfizer collaborated with BIND Therapeutics Inc for the development of nanoparticles, called Accurins.

The growing adoption of injectable nanomedicines for cancer treatment is expected to boost revenues generated from injectable nanomedicines thereby boost the growth of the global injectable nanomedicines market. Cancer is one of the leading causes of deaths globally, with approximately 1,688,780 new cases and 600,920 deaths in 2017. Researchers note that efficacy of traditional cancer therapeutics is often modest to negligible owing to the low specificity and stability. For obtaining optimal therapeutic effects, the right drug should be delivered at the targeted microenvironment at the right time with the right concentration.

Injectable nanomedicines are advantageous over all the conventional medicines for cancer therapy. Injectable nanomedicines contain drugs loaded in nanoparticles, which help to overcome the biological barriers, improve the efficacy and reduce morbidity.  These medicines further improve the bioavailability and toxicity profile of cancer treatments. All these factors are projected to drive the growth of the global injectable nanomedicines market during the forecast period.

The global injectable nanomedicines market is segmented based on drug type, applications, and end user.

Based on drug type, the injectable nanomedicines market has been segmented into liposomes, micelles, nanocrystals, polymeric nanoparticles, metallic nanoparticles, mesoporous silica nanoparticles and others. The liposomal drug type is projected to be the leading segment holding maximum share in the global injectable nanomedicines market. Liposomes mimic biological cells and are highly biocompatible, which makes them an ideal candidate for a drug delivery system among global injectable nanomedicines manufacturers.

Based on application, the injectable nanomedicines market has been segmented into cancer, central nervous system disease, cardiovascular disease, infection control, inflammatory disease and others. In terms of revenue, cancer application dominated the global injectable nanomedicines market in 2017 and is projected to continue to do so throughout the forecast period. After cancer, CNS application is expected to account for significant share in the market.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/25999

The global injectable nanomedicines market   is competitive, with large number of players. However, availability of adequate sterile drug manufacturing facilities is estimated to pose serious problem in injectable nanomedicines market throughout the forecast period, especially in emerging markets.

About Us: Persistence Market Research

Contact Us:

Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353

Japan Office: 1-2-1 Kinshi Arca Central Building
14/F Tokyo, 130-0013, Japan
Call 1-888-863-3700

Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

Continue Reading

Why pay for news and opinions when you can get them for free?

       Subscribe for free now!


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Posts